Variant report
Variant | nsv971918 |
---|---|
Chromosome Location | chr10:45671966-45679201 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:11)
- CpG islands (count:183)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:11 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | IRF1 | chr10:45678662-45678990 | K562 | blood: | n/a | n/a |
2 | IRF1 | chr10:45678743-45678890 | K562 | blood: | n/a | n/a |
3 | IRF1 | chr10:45678626-45678935 | K562 | blood: | n/a | n/a |
4 | KAP1 | chr10:45674054-45674205 | K562 | blood: | n/a | n/a |
5 | MAX | chr10:45672689-45672764 | NB4 | blood: | n/a | chr10:45672702-45672712 |
6 | MXI1 | chr10:45672789-45672891 | K562 | blood: | n/a | n/a |
7 | MYC | chr10:45678851-45678862 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | MYC | chr10:45678883-45678888 | NB4 | blood: | n/a | n/a |
9 | POLR2A | chr10:45672471-45672529 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | RCOR1 | chr10:45672758-45672793 | K562 | blood: | n/a | n/a |
11 | YY1 | chr10:45678271-45678466 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:45675577-45675627 | Hela-S3 | cervix: | n/a |
2 | chr10:45675633-45675683 | Caco-2 | colon: | n/a |
3 | chr10:45675680-45675730 | HepG2 | liver: | n/a |
4 | chr10:45675633-45675683 | HPAEpiC | pulmonary alveolar: | n/a |
5 | chr10:45675680-45675730 | HPAEpiC | pulmonary alveolar: | n/a |
6 | chr10:45675633-45675683 | SK-N-SH | brain: | n/a |
7 | chr10:45675633-45675683 | Hepatocyte | liver: | n/a |
8 | chr10:45675577-45675627 | Caco-2 | colon: | n/a |
9 | chr10:45675680-45675730 | HAEpiC | amniotic membrane: | n/a |
10 | chr10:45675680-45675730 | AG04450 | lung: | fetal |
11 | chr10:45675633-45675683 | AG04450 | lung: | fetal |
12 | chr10:45675577-45675627 | AG09319 | gingival: | n/a |
13 | chr10:45675633-45675683 | HepG2 | liver: | n/a |
14 | chr10:45675633-45675683 | H1-hESC | embryonic stem cell: | embryo |
15 | chr10:45675633-45675683 | U87 | brain: | n/a |
16 | chr10:45675577-45675627 | NHDF-neo | bronchial: | n/a |
17 | chr10:45675577-45675627 | U87 | brain: | n/a |
18 | chr10:45675633-45675683 | HCPEpiC | choroid plexus: | n/a |
19 | chr10:45675633-45675683 | HNPCEpiC | eye: | n/a |
20 | chr10:45675633-45675683 | NB4 | blood: | n/a |
21 | chr10:45675633-45675683 | RPTEC | kidney: | n/a |
22 | chr10:45675633-45675683 | HEK293 | kidney: | embryo |
23 | chr10:45675577-45675627 | PFSK-1 | brain: | n/a |
24 | chr10:45675680-45675730 | BJ | skin: | n/a |
25 | chr10:45675633-45675683 | NHDF-neo | bronchial: | n/a |
26 | chr10:45675680-45675730 | GM06990 | blood: | n/a |
27 | chr10:45675680-45675730 | IMR90 | lung: | fetal |
28 | chr10:45675633-45675683 | SKMC | muscle: | n/a |
29 | chr10:45675680-45675730 | GM12878 | blood: | n/a |
30 | chr10:45675680-45675730 | SKMC | muscle: | n/a |
31 | chr10:45675633-45675683 | NH-A | brain: | n/a |
32 | chr10:45675680-45675730 | PrEC | prostate: | n/a |
33 | chr10:45675633-45675683 | PANC-1 | pancreas: | n/a |
34 | chr10:45675577-45675627 | HepG2 | liver: | n/a |
35 | chr10:45675577-45675627 | AoSMC | blood vessel: | n/a |
36 | chr10:45675680-45675730 | HMEC | breast: | n/a |
37 | chr10:45675680-45675730 | MCF-7 | breast: | n/a |
38 | chr10:45675577-45675627 | A549 | lung: | n/a |
39 | chr10:45675577-45675627 | ProgFib | skin: | n/a |
40 | chr10:45675577-45675627 | AG04449 | skin: | fetal |
41 | chr10:45675633-45675683 | IMR90 | lung: | fetal |
42 | chr10:45675577-45675627 | SK-N-MC | brain: | n/a |
43 | chr10:45675577-45675627 | SKMC | muscle: | n/a |
44 | chr10:45675633-45675683 | HCM | heart: | n/a |
45 | chr10:45675577-45675627 | HCF | heart: | n/a |
46 | chr10:45675680-45675730 | NHDF-neo | bronchial: | n/a |
47 | chr10:45675577-45675627 | HEEpiC | esophagus: | n/a |
48 | chr10:45675633-45675683 | HAEpiC | amniotic membrane: | n/a |
49 | chr10:45675633-45675683 | GM06990 | blood: | n/a |
50 | chr10:45675633-45675683 | A549 | lung: | n/a |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:45673653..45675477-chr10:45677321..45679221,2 | K562 | blood: | |
2 | chr10:45494680..45497168-chr10:45675442..45677371,2 | K562 | blood: | |
3 | chr10:45673653..45675477-chr10:45677321..45679221,2 | K562 | blood: | |
4 | chr10:45673165..45677202-chr10:45678075..45681365,4 | K562 | blood: | |
5 | chr10:45674490..45676456-chr10:45679865..45681519,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR13A1-1 | chr10:45676530-45676875 | ENSG00000227683 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227683 | TF binding region |
ENSG00000227683 | CpG island |
ENSG00000165512 | chromatin interactions |
ENSG00000165511 | chromatin interactions |
ENSG00000227683 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188504614 | chr10:45671968-45671969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557001178 | chr10:45671998-45671999 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115756548 | chr10:45672051-45672052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542563519 | chr10:45672098-45672099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561329111 | chr10:45672117-45672118 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs573890493 | chr10:45672126-45672127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541304351 | chr10:45672136-45672137 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142101023 | chr10:45672154-45672155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs34382959 | chr10:45672156-45672157 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs181690854 | chr10:45672199-45672200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs199584260 | chr10:45672229-45672230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548059687 | chr10:45672231-45672232 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs151174266 | chr10:45672293-45672294 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140051819 | chr10:45672377-45672378 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs3851263 | chr10:45672429-45672430 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs185082768 | chr10:45672440-45672441 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535033972 | chr10:45672476-45672477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145247137 | chr10:45672508-45672509 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs372606684 | chr10:45672531-45672532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs138125706 | chr10:45672545-45672546 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs538807927 | chr10:45672574-45672575 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557035869 | chr10:45672611-45672612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs144759300 | chr10:45672624-45672625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs370796007 | chr10:45672650-45672651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs12246809 | chr10:45672670-45672671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs144753686 | chr10:45672709-45672710 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536739469 | chr10:45672784-45672785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs111685738 | chr10:45672796-45672797 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs554698227 | chr10:45672828-45672829 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573170840 | chr10:45672839-45672840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540991169 | chr10:45672844-45672845 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375688253 | chr10:45672847-45672848 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190769924 | chr10:45672862-45672863 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577925022 | chr10:45672880-45672881 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs545177689 | chr10:45672883-45672884 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs10900174 | chr10:45672898-45672899 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs530664482 | chr10:45672903-45672904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs11239373 | chr10:45672920-45672921 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs372003363 | chr10:45672934-45672935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371604524 | chr10:45672958-45672959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144268514 | chr10:45672990-45672991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs1252924 | chr10:45673024-45673025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568169766 | chr10:45673053-45673054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10900175 | chr10:45673057-45673058 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs148326655 | chr10:45673094-45673095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112677474 | chr10:45673101-45673102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571558218 | chr10:45673125-45673126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs577619230 | chr10:45673154-45673155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371138135 | chr10:45673155-45673156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532662027 | chr10:45673181-45673182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 22241247 | CNVD |
Intellectual disability | 21811512 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Obesity | 21956041 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21785460 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 17289997 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Autism | 19287141 | CNVD |
Intellectual disability | 21948486 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Non-syndromic sensorineural hearing loss | 19587683 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:45671200-45672600 | Enhancers | Fetal Heart | heart |
2 | chr10:45671600-45676200 | Weak transcription | Placenta | Placenta |
3 | chr10:45671600-45676400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr10:45671800-45673000 | Enhancers | K562 | blood |
5 | chr10:45674400-45675200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr10:45675000-45675200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr10:45675200-45675600 | Enhancers | Fetal Stomach | stomach |
8 | chr10:45675200-45676600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr10:45675400-45675600 | Enhancers | Adipose Nuclei | Adipose |
10 | chr10:45675400-45677200 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr10:45676000-45676200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr10:45676000-45676600 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
13 | chr10:45676000-45676600 | Enhancers | Spleen | Spleen |
14 | chr10:45676000-45677200 | Enhancers | Aorta | Aorta |
15 | chr10:45676200-45676400 | Enhancers | Right Atrium | heart |
16 | chr10:45676200-45677600 | Enhancers | Placenta | Placenta |
17 | chr10:45676200-45679400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr10:45676400-45677000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
19 | chr10:45676400-45677000 | Weak transcription | Right Atrium | heart |
20 | chr10:45676400-45677400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
21 | chr10:45676600-45677200 | Enhancers | Adipose Nuclei | Adipose |
22 | chr10:45676600-45677600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr10:45676800-45677400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |